SRS for NSCLC With Oligo-residual Intracranial Disease After First-line 3rd Generation EGFR-TKI
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anwen Liu
Nanchang University Second Affiliated Hospital
Principal Investigator - Bing Lu
The Affiliated Hospital Of Guizhou Medical University
Principal Investigator - Chuangzhou Rao
Ningbo No.2 Hospital
Principal Investigator - Dejun XIng
Jilin Provincial Tumor Hospital
Principal Investigator - Fang Liu
Chinese PLA General Hospital
Principal Investigator - Guang Han
Hubei Cancer Hospital
Principal Investigator - Guomei Tai
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
Principal Investigator - Haihua Yang
Taizhou Hospital Affiliated to Wenzhou Medical University
Principal Investigator - Hongqing Zhuang
Peking University Third Hospital
Principal Investigator - Hui Zhu
Shandong Cancer Hospital and Institute
Principal Investigator - Jiancheng Li
Fujian Cancer Hospital
Principal Investigator - Jichen Ren
Jilin Provincial Tumor Hospital
Principal Investigator - Jinjun Ye
Jiangsu Cancer Institute & Hospital
Principal Investigator - Jiwei Liu
The First Affiliated Hospital of Dalian Medical University
Principal Investigator - Lin Wu
Hunan Cancer Hospital
Principal Investigator - Qian Chu
Tongji Hospital
Principal Investigator - Rongrong Zhou
Xiangya Hospital of Central South University
Principal Investigator - Xiaojia Cui
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
Principal Investigator - Xiaorong Dong
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Principal Investigator - Xuwei Cai
Shanghai Chest Hospital
Principal Investigator - Yanyang Wang
General Hospital of Ningxia Medical University
Principal Investigator - Yong Mao
Affiliated Hospital of Jiangnan University
Principal Investigator - Zhengfei Zhu, MD
Fudan University
Principal Investigator - Zhenzhou Yang
The Second Affiliated Hospital of Chongqing Medical University
Principal Investigator - Zhiyong Yuan
Tianjin Medical University Cancer Institute and Hospital
Principal Investigator - Zhongyi Dong
Nanfang Hospital, Southern Medical University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Aug 2023
- Primary completion
- 10 Aug 2027
- Completion
- 10 Aug 2028
- Last update posted
- 15 Sept 2025
- Registered enrollment
- 202
- Registry id
- NCT06020066
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.